Mr. Stephen Davis reports

FREQUENCY EXCHANGE ANNOUNCES INCREASE IN SIZE OF PRIVATE PLACEMENT

Further to the news release dated July 21, 2025, Frequency Exchange Corp. has increased the size of its non-brokered private placement from $1.5-million to $2-million. The upsized private placement is composed of the sale of up to eight million units at a price of 25 cents per unit. Each unit is composed of one common share and one common share purchase warrant, having an exercise price of 40 cents per warrant for a period of 24 months from the date of closing of the private placement.

In the event that, during the 24-month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least 70 cents per common share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not fewer than 21 days following the date upon which notice of the accelerated expiry date is provided by the company by way of a news release.

Finders' fees of up to 8 per cent in cash and 8 per cent in finders' warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing.

The private placement is subject to TSX Venture Exchange approval, and all securities issued will be subject to a four-month hold period.

The capital will be used to expand the team, cover general operating costs, provide a technology upgrade, pay down accrued debt, and support marketing initiatives in both the consumer and public markets. The capital will also be used to purchase increased inventory prompted by the greater demand following the expansion of FREmedica Technologies Inc. patented technology rights to include all general wellness markets for wearables for humans and animals worldwide. All terms remain the same.

About Frequency Exchange Corp.

Based in British Columbia, Canada, Frequency Exchange is publicly traded. Frequency Exchange acquired FREmedica in 2022. FREmedica is now a wholly owned and operating subsidiary of Frequency Exchange. FREmedica's business is focused on development and wellness programs. Nikki means victor of the people, bringing wellness programs to all walks of life. FREmedica began with the development of a specialized Lyme support program designed to help people struggling with Lyme disease. Now FREmedica, through Nikki, delivers wellness programs to assist with issues, including sleep, pain, energy, immunity and many more. Nikki delivers wellness programs to restore and improve communication in the network of trillions of cells that make up the human body. Strong cell communication is essential to good health.

Health can be disrupted by physical, mental and emotional trauma. For example, poor sleep can be a symptom of pain, stress and fatigue stemming from poor cell communication. Nikki delivers specific frequencies into the body for the purpose of restoring proper cell function. Categories of wellness programs continue to grow. Nikki wellness technology, combined with frequency-based wellness programs, is the result of years of development and experimentation with advanced bioenergetic technology. In third party quality-of-life testing over an eight-week period, Nikki proved to provide an unprecedented level of benefits ranging from better sleep and reduced pain to less anxiety and greater energy, with 90 per cent of the test subjects experiencing improvement in overall wellness.

We seek Safe Harbor.